PRMT1 as a therapeutic target in diffuse large B-cell lymphoma.

被引：0
|
作者：
Goverdhan, Aarthi [1 ]
Lee, Heng-Huan [1 ]
Havranek, Ondrej [1 ]
Davis, Richard Eric [1 ]
Hung, Mien-Chie [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2017年 / 23卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] PKCβ:: A rational therapeutic target in diffuse large B-cell lymphoma.
    Wu, EX
    Aguiar, RCT
    Savage, KJ
    Kutok, JL
    Wang, FF
    Aster, JC
    Shipp, MA
    BLOOD, 2002, 100 (11) : 202A - 202A
  • [2] CD38 expression in Diffuse Large B-cell Lymphoma. A new therapeutic target?
    Farinha, Pedro
    Ben-Neriah, Susana
    Mottok, Anja
    Ennishi, Daisuke
    Meissner, Barbara
    Boyle, Merrill
    Villa, Diego
    Savage, Kerry
    Sehn, Laurie H.
    Connors, Joseph
    Slack, Graham
    Gascoyne, Randy
    Steidl, Christian
    Scott, David
    MODERN PATHOLOGY, 2018, 31 : 514 - 515
  • [3] CD38 expression in Diffuse Large B-cell Lymphoma. A new therapeutic target?
    Farinha, Pedro
    Ben-Neriah, Susana
    Mottok, Anja
    Ennishi, Daisuke
    Meissner, Barbara
    Boyle, Merrill
    Villa, Diego
    Savage, Kerry
    Sehn, Laurie H.
    Connors, Joseph
    Slack, Graham
    Gascoyne, Randy
    Steidl, Christian
    Scott, David
    LABORATORY INVESTIGATION, 2018, 98 : 514 - 515
  • [4] Fostamatinib for the treatment of diffuse large B-cell lymphoma.
    Arkenau, Hendrik-Tobias
    Patrikidou, Anna
    Flinn, Ian
    Hylton, Jonas C.
    Tong, Sandra
    Ardeshna, Kirit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Unusual presentation of diffuse large B-cell lymphoma.
    Persing, B.
    Herrin, V.
    Elkins, S.
    Files, J.
    Bigelow, C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S268 - S268
  • [6] Expression of mTOR in diffuse large B-cell lymphoma.
    Gopaluni, Srivalli
    Vajpayee, Neerja
    Newman, Nancy
    Thakral, Charu
    Husain, Juhi
    Gajra, Ajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Conditional survival of patients with diffuse large B-cell lymphoma.
    Moller, MB
    Pedersen, NT
    Christensen, BE
    BLOOD, 2005, 106 (11) : 542A - 542A
  • [8] Carcinoma erysipelatoides associated with diffuse large B-cell lymphoma.
    Khan, B. Q.
    Gandhi, M.
    Edmonds, H.
    Ahmad, K.
    Rasberry, R. D.
    Corbett, C. E.
    Jakkola, A. F.
    Carbone, L. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S313 - S313
  • [9] Heat shock protein 90 (HSP90) is a rational therapeutic target in diffuse large B-cell lymphoma.
    Abramson, Jeremy S.
    Chen, Wen
    Takahashi, Hidenobu
    Juszczynski, Przemyslaw
    Kutok, Jeffery L.
    Shipp, Margaret A.
    BLOOD, 2006, 108 (11) : 249A - 249A
  • [10] SIRT6 As a Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma
    Yang, Juan
    Li, Ying
    Zhang, Ya
    Zhou, Xiangxiang
    Wang, Xin
    BLOOD, 2018, 132
12345